PLUS THERAPEUTICS, INC. Income Statement
PSTV|10 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
PLUS THERAPEUTICS, INC. reported $6M in revenue and $13M in net loss for FY2025. Revenue has declined at a 0.0% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8M | $4.9M | $2.7M | $4.7M | $4.8M | $7.1M | $8.7M | $8.0M | $8.3M | $5.8M |
| Cost of Revenue | - | - | $1.3M | - | $3.2M | $3.4M | $4.0M | $3.8M | $3.9M | $3.4M |
| Gross Profit | - | - | - | $1.9M | $1.7M | $3.7M | $4.7M | $4.1M | $4.3M | $2.4M |
| SG&A Expense | $9.9M | $8.5M | $7.6M | $8.6M | $9.8M | $16.0M | $15.7M | $14.7M | $12.6M | $10.4M |
| R&D Expense | $10.6M | $9.7M | $11.7M | $16.2M | $19.0M | $17.1M | $13.6M | $10.9M | $9.7M | $12.2M |
| Operating Income | -$14.7M | -$13.3M | -$20.7M | -$19.7M | -$15.3M | -$30.7M | -$28.4M | -$29.4M | -$25.3M | -$21.5M |
| Interest Expense | - | - | $2.0M | $2.6M | $3.4M | $3.4M | $3.4M | $2.8M | $2.1M | $1.4M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | - | - | - | - | - |
| Net Income | -$13.0M | -$13.3M | -$22.7M | -$22.0M | -$18.7M | -$26.2M | -$32.3M | -$32.5M | -$27.5M | -$23.2M |
| EPS (Basic) | -$1.95 | -$4.24 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$2.34 | -$4.24 | -$8.23 | -$1.28 | -$2.07 | -$0.39 | -$0.55 | -$0.61 | -$0.60 | -$0.65 |
| Shares Outstanding | 5.9M | 4.4M | 5.8M | 200.0M | 13.0M | 99.3M | 71.3M | 65.9M | 56.6M | 52.0M |
| Gross Margin | - | - | - | 41.7% | 34.2% | 52.0% | 54.1% | 51.9% | 52.6% | 41.9% |
| Operating Margin | -252.3% | -271.1% | -769.2% | -423.2% | -316.0% | -430.8% | -326.3% | -368.4% | -306.8% | -369.1% |
| Profit Margin | -222.8% | -271.0% | -843.7% | -473.5% | -387.4% | -367.6% | -370.6% | -406.5% | -333.1% | -397.7% |